Le Bao Huy, Nguyen Pham Thao-Ngan, Nguyen Huong-Dung Thi, Phan Tri Cuong, Nguyen Le Han My, Truyen Thien Tan Tri Tai, Lam Tam Duc
Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam (B.H. Le).
University of Medicine Phan and Pharmacy, Ho Chi Minh City, Vietnam (Pham).
AJOG Glob Rep. 2025 Jun 4;5(3):100526. doi: 10.1016/j.xagr.2025.100526. eCollection 2025 Aug.
Cervical cancer continues to be a significant global health challenge, with Vietnam facing similar concerns. Although there has been some progress in lowering its incidence and mortality rates, a comprehensive understanding of long-term trends and the factors driving these changes remains limited.
This study aimed to analyze the burden and risk factors of cervical cancer in Vietnam over a 3-decade period, from 1990 to 2021 with projection to 2050.
Our study used data from the Global Burden of Disease (GBD) 2021 estimates, developed by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. This dataset includes metrics such as incidence, prevalence, mortality, and disability-adjusted life years (DALYs), all presented as age-standardized rates (ASRs) per 100,000 individuals. We analyzed trends from 1990 to 2021 and projections for 2022 to 2050 using the Joinpoint regression model. Additionally, we examined ASRs for death and DALYs attributed to cervical cancer-related risk factors.
In 2021, cervical cancer accounted for approximately 4369 deaths (95% UI: 3345-5713) in Vietnam, with ASRs for incidence, prevalence, and mortality at 16.50 per 100,000 (95% UI: 12.49-21.83), 88.11 per 100,000 (95% UI: 65.32-116.75), and 7.66 per 100,000 (95% UI: 5.90-9.94), respectively. From 1990 to 2021, trends in incidence, DALYs, and mortality followed 3 phases: a decrease in incidence from 1990 to 1992 (APC: -2.42%, 95% CI: -3.56 to -0.85), an increase from 1992 to 1996 (APC: 2.69%, 95% CI: 2.09-3.65), and a subsequent decrease from 1996 to 2008 (APC: -0.68%, 95% CI: -0.86 to -0.57), with no significant change from 2008 to 2021. Projections from 2022 to 2050 suggest an all-age DALYs rate of 147.55 (95% UI: 105.14-198.31) in 2050, with an expected rise until 2039 followed by a decline, reflecting an annual percent change of -0.2% (95% CI: -0.07 to -0.55). Major risk factors for cervical cancer in Vietnam include smoking and unsafe sexual practices, with associated age-standardized mortality rates of 0.31 (95% UI: 0.16-0.53) and 7.66 (95% CI: 5.89-9.80) per year, respectively.
The study reveals that, despite some progress in reducing the incidence, mortality, and DALYs associated with cervical cancer in Vietnam over the past 3 decades, the overall burden remains substantial. This study underscores the impact of key risk factors, including smoking and unsafe sex. Future research is needed to evaluate effective interventions and healthcare policies that could reduce the burden of cervical cancer and improve women's health outcomes in Vietnam.
宫颈癌仍然是一项重大的全球健康挑战,越南也面临着类似的问题。尽管在降低其发病率和死亡率方面取得了一些进展,但对长期趋势以及推动这些变化的因素的全面了解仍然有限。
本研究旨在分析1990年至2021年这三十年期间越南宫颈癌的负担和风险因素,并预测至2050年。
我们的研究使用了华盛顿大学健康指标与评估研究所(IHME)编制的《2021年全球疾病负担(GBD)》估计数据。该数据集包括发病率、患病率、死亡率和伤残调整生命年(DALYs)等指标,均以每10万人的年龄标准化率(ASRs)呈现。我们使用Joinpoint回归模型分析了1990年至2021年的趋势以及2022年至2050年的预测情况。此外,我们还研究了归因于宫颈癌相关风险因素的死亡年龄标准化率和伤残调整生命年。
2021年,越南宫颈癌导致约4369人死亡(95%不确定区间:3345 - 5713),发病率、患病率和死亡率的年龄标准化率分别为每10万人16.50(95%不确定区间:12.49 - 21.83)、每10万人88.11(95%不确定区间:65.32 - 116.75)和每10万人7.66(95%不确定区间:5.90 - 9.94)。从1990年到2021年,发病率、伤残调整生命年和死亡率的趋势经历了三个阶段:1990年至1992年发病率下降(年度百分比变化:-2.42%,95%置信区间:-3.56至-0.85),1992年至1996年上升(年度百分比变化:2.69%,95%置信区间:2.09 - 3.65),随后1996年至2008年下降(年度百分比变化:-0.68%,95%置信区间:-0.86至-0.57),2008年至2021年无显著变化。2022年至2050年的预测表明,2050年全年龄段伤残调整生命年率为147.55(95%不确定区间:105.14 - 198.31),预计到2039年上升,随后下降,反映出年度百分比变化为-0.2%(95%置信区间:-0.07至-0.55)。越南宫颈癌的主要风险因素包括吸烟和不安全的性行为,相关的年龄标准化死亡率分别为每年0.31(95%不确定区间:0.16 - 0.53)和7.66(95%置信区间:5.89 - 9.80)。
该研究表明,尽管在过去三十年中越南在降低与宫颈癌相关的发病率、死亡率和伤残调整生命年方面取得了一些进展,但总体负担仍然很大。这项研究强调了包括吸烟和不安全性行为在内的关键风险因素的影响。未来需要开展研究以评估有效的干预措施和医疗保健政策,从而减轻越南宫颈癌的负担并改善女性的健康状况。